Viz.ai has raised $177.1M across 1 funding round, plus 2 undated rounds. The latest round valued Viz.ai at $50M post-money.
Viz.ai is backed by Khosla Ventures and Insight Partners. The healthcare AI company was founded in 2016 by neurosurgeon Dr. Chris Mansi and machine learning researcher Dr. David Golan, who set out to speed up clinical decision-making after treatment delays cost a patient her life.
1 funding round, the latest highlighted.
Viz.ai was founded in 2016, United States.
No date is disclosed for this round.
A primary round — the company sells new shares to investors it selects. $6.1M raised.
No filing has been made.
1 dated round, newest first.
Tiger GlobalLEAD
Insight PartnersLEAD
Scale Venture PartnersLEAD
Khosla VenturesViz.ai builds an AI-powered care coordination platform used by hospitals to speed diagnosis and treatment, running more than 50 FDA-cleared algorithms that analyze CT scans, EKGs and echocardiograms in real time.
Viz.ai is private, so its shares are not available on public markets.
Viz.ai operates in Artificial Intelligence.
Viz.ai's headquarters is in San Francisco, California.
Viz.ai has about 328 employees.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
